BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhao YS, Zhu S, Li XW, Wang F, Hu FL, Li DD, Zhang WC, Li X. Association between NSAIDs use and breast cancer risk: a systematic review and meta-analysis. Breast Cancer Res Treat. 2009;117:141-150. [PMID: 18979210 DOI: 10.1007/s10549-008-0228-6] [Cited by in Crossref: 59] [Cited by in F6Publishing: 60] [Article Influence: 4.2] [Reference Citation Analysis]
Number Citing Articles
1 O'Hanlon CE, Amede KG, O'Hear MR, Janjic JM. NIR-labeled perfluoropolyether nanoemulsions for drug delivery and imaging. J Fluor Chem 2012;137:27-33. [PMID: 22675234 DOI: 10.1016/j.jfluchem.2012.02.004] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 3.5] [Reference Citation Analysis]
2 van Herk-sukel MP, van de Poll-franse LV, Lemmens VE, Vreugdenhil G, Pruijt JF, Coebergh JWW, Herings RM. New opportunities for drug outcomes research in cancer patients: The linkage of the Eindhoven Cancer Registry and the PHARMO Record Linkage System. European Journal of Cancer 2010;46:395-404. [DOI: 10.1016/j.ejca.2009.09.010] [Cited by in Crossref: 86] [Cited by in F6Publishing: 81] [Article Influence: 7.2] [Reference Citation Analysis]
3 Hasawi NA, Alkandari MF, Luqmani YA. Phosphofructokinase: A mediator of glycolytic flux in cancer progression. Critical Reviews in Oncology/Hematology 2014;92:312-21. [DOI: 10.1016/j.critrevonc.2014.05.007] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 6.1] [Reference Citation Analysis]
4 Friis S, Kesminiene A, Espina C, Auvinen A, Straif K, Schüz J. European Code against Cancer 4th Edition: Medical exposures, including hormone therapy, and cancer. Cancer Epidemiology 2015;39:S107-19. [DOI: 10.1016/j.canep.2015.08.003] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 4.1] [Reference Citation Analysis]
5 Lubovac-Pilav Z, Borràs DM, Ponce E, Louie MC. Using expression profiling to understand the effects of chronic cadmium exposure on MCF-7 breast cancer cells. PLoS One 2013;8:e84646. [PMID: 24376830 DOI: 10.1371/journal.pone.0084646] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
6 Green VL. Breast cancer risk assessment, prevention, and the future. Obstet Gynecol Clin North Am 2013;40:525-49. [PMID: 24021255 DOI: 10.1016/j.ogc.2013.05.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
7 Wang B, Wu L, Chen J, Dong L, Chen C, Wen Z, Hu J, Fleming I, Wang DW. Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets. Signal Transduct Target Ther 2021;6:94. [PMID: 33637672 DOI: 10.1038/s41392-020-00443-w] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
8 Hurwitz LM, Michels KA, Cook MB, Pfeiffer RM, Trabert B. Associations between daily aspirin use and cancer risk across strata of major cancer risk factors in two large U.S. cohorts. Cancer Causes Control 2021;32:57-65. [PMID: 33104910 DOI: 10.1007/s10552-020-01357-2] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Mallick S, Benson R, Julka PK. Breast cancer prevention with anti-estrogens: review of the current evidence and future directions. Breast Cancer 2016;23:170-7. [PMID: 26439380 DOI: 10.1007/s12282-015-0647-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
10 Wang X, Kingsley PJ, Marnett LJ, Eling TE. The role of NAG-1/GDF15 in the inhibition of intestinal polyps in APC/Min mice by sulindac. Cancer Prev Res (Phila) 2011;4:150-60. [PMID: 21205743 DOI: 10.1158/1940-6207.CAPR-10-0196] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
11 Lazzeroni M, Petrera M, Marra D, Decensi A. Aspirin and Breast Cancer Prevention. Curr Breast Cancer Rep 2013;5:202-7. [DOI: 10.1007/s12609-013-0115-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
12 Gates MA, Tworoger SS, Eliassen AH, Missmer SA, Hankinson SE. Analgesic use and sex steroid hormone concentrations in postmenopausal women. Cancer Epidemiol Biomarkers Prev 2010;19:1033-41. [PMID: 20332258 DOI: 10.1158/1055-9965.EPI-09-0975] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 3.3] [Reference Citation Analysis]
13 Layeequr Rahman R, Pruthi S. Chemoprevention of Breast Cancer: The Paradox of Evidence versus Advocacy Inaction. Cancers (Basel) 2012;4:1146-60. [PMID: 24213502 DOI: 10.3390/cancers4041146] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
14 Park SK, Kang D, Kim Y, Yoo K. Epidemiologic Characteristics of the Breast Cancer in Korea. J Korean Med Assoc 2009;52:937. [DOI: 10.5124/jkma.2009.52.10.937] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
15 Thun MJ, Jacobs EJ, Patrono C. The role of aspirin in cancer prevention. Nat Rev Clin Oncol 2012;9:259-67. [PMID: 22473097 DOI: 10.1038/nrclinonc.2011.199] [Cited by in Crossref: 318] [Cited by in F6Publishing: 284] [Article Influence: 31.8] [Reference Citation Analysis]
16 de Pedro M, Baeza S, Escudero MT, Dierssen-Sotos T, Gómez-Acebo I, Pollán M, Llorca J. Effect of COX-2 inhibitors and other non-steroidal inflammatory drugs on breast cancer risk: a meta-analysis. Breast Cancer Res Treat 2015;149:525-36. [PMID: 25589172 DOI: 10.1007/s10549-015-3267-9] [Cited by in Crossref: 42] [Cited by in F6Publishing: 31] [Article Influence: 6.0] [Reference Citation Analysis]
17 Chen Y, Kang L, Zhu Y, Jing C, Chen Y, Kang L, Zhu Y. Non-steroidal anti-inflammatory drugs and risk of mortality in lung cancer: A meta-analysis of 5 prospective cohorts studies. Medicine (Baltimore) 2019;98:e16806. [PMID: 31393411 DOI: 10.1097/MD.0000000000016806] [Reference Citation Analysis]
18 Sun X, Glynn DJ, Hodson LJ, Huo C, Britt K, Thompson EW, Woolford L, Evdokiou A, Pollard JW, Robertson SA, Ingman WV. CCL2-driven inflammation increases mammary gland stromal density and cancer susceptibility in a transgenic mouse model. Breast Cancer Res 2017;19:4. [PMID: 28077158 DOI: 10.1186/s13058-016-0796-z] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 6.2] [Reference Citation Analysis]
19 Clarke CA, Canchola AJ, Moy LM, Neuhausen SL, Chung NT, Lacey JV Jr, Bernstein L. Regular and low-dose aspirin, other non-steroidal anti-inflammatory medications and prospective risk of HER2-defined breast cancer: the California Teachers Study. Breast Cancer Res 2017;19:52. [PMID: 28460643 DOI: 10.1186/s13058-017-0840-7] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 7.0] [Reference Citation Analysis]
20 Thabet NA, El-guendy N, Mohamed MM, Shouman SA. Suppression of macrophages- Induced inflammation via targeting RAS and PAR-4 signaling in breast cancer cell lines. Toxicology and Applied Pharmacology 2019;385:114773. [DOI: 10.1016/j.taap.2019.114773] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
21 Lu L, Shi L, Zeng J, Wen Z. Aspirin as a potential modality for the chemoprevention of breast cancer: A dose-response meta-analysis of cohort studies from 857,831 participants. Oncotarget 2017;8:40389-401. [PMID: 28418881 DOI: 10.18632/oncotarget.16315] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 7.5] [Reference Citation Analysis]
22 Royds J, Khan AH, Buggy DJ. An Update on Existing Ongoing Prospective Trials Evaluating the Effect of Anesthetic and Analgesic Techniques During Primary Cancer Surgery on Cancer Recurrence or Metastasis. International Anesthesiology Clinics 2016;54:e76-83. [DOI: 10.1097/aia.0000000000000123] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
23 Hamy AS, Derosa L, Valdelièvre C, Yonekura S, Opolon P, Priour M, Guerin J, Pierga JY, Asselain B, De Croze D, Pinheiro A, Lae M, Talagrand LS, Laas E, Darrigues L, Grandal B, Marangoni E, Montaudon E, Kroemer G, Zitvogel L, Reyal F. Comedications influence immune infiltration and pathological response to neoadjuvant chemotherapy in breast cancer. Oncoimmunology 2020;9:1677427. [PMID: 32002287 DOI: 10.1080/2162402X.2019.1677427] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Schwab RB, Kato S, Crain B, Pu M, Messer K, Weidner N, Blair SL, Wallace AM, Carson DA, Parker BA. A window-of-opportunity biomarker study of etodolac in resectable breast cancer. Cancer Med 2015;4:1583-8. [PMID: 26275572 DOI: 10.1002/cam4.512] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
25 Chen J, Hu X, Cui J. Shikonin, vitamin K3 and vitamin K5 inhibit multiple glycolytic enzymes in MCF-7 cells. Oncol Lett 2018;15:7423-32. [PMID: 29725454 DOI: 10.3892/ol.2018.8251] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
26 Li S, Liu Y, Zeng Z, Peng Q, Li R, Xie L, Qin X, Zhao J. Association between non-steroidal anti-inflammatory drug use and melanoma risk: a meta-analysis of 13 studies. Cancer Causes Control 2013;24:1505-16. [PMID: 23677334 DOI: 10.1007/s10552-013-0227-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
27 Wang X, Baek SJ, Eling T. COX inhibitors directly alter gene expression: role in cancer prevention? Cancer Metastasis Rev 2011;30:641-57. [PMID: 22020924 DOI: 10.1007/s10555-011-9301-4] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
28 Brenner DR, Scherer D, Muir K, Schildkraut J, Boffetta P, Spitz MR, Le Marchand L, Chan AT, Goode EL, Ulrich CM, Hung RJ. A review of the application of inflammatory biomarkers in epidemiologic cancer research. Cancer Epidemiol Biomarkers Prev 2014;23:1729-51. [PMID: 24962838 DOI: 10.1158/1055-9965.EPI-14-0064] [Cited by in Crossref: 71] [Cited by in F6Publishing: 33] [Article Influence: 8.9] [Reference Citation Analysis]
29 Wilson LE, Kim S, Xu Z, Harlid S, Sandler DP, Taylor JA. Non-Steroidal Anti-Inflammatory Drug Use and Genomic DNA Methylation in Blood. PLoS One 2015;10:e0138920. [PMID: 26393518 DOI: 10.1371/journal.pone.0138920] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
30 Klein T, Benders J, Roth F, Baudler M, Siegle I, Kömhoff M. Expression of Prostacyclin-Synthase in Human Breast Cancer: Negative Prognostic Factor and Protection against Cell Death In Vitro. Mediators Inflamm 2015;2015:864136. [PMID: 26265889 DOI: 10.1155/2015/864136] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
31 Bauer SR, Fortner RT, Gates MA, Eliassen AH, Hankinson SE, Tworoger SS. Analgesic use in relation to sex hormone and prolactin concentrations in premenopausal women. Cancer Causes Control 2013;24:1087-97. [PMID: 23515936 DOI: 10.1007/s10552-013-0186-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
32 Cole SW. Chronic inflammation and breast cancer recurrence. J Clin Oncol 2009;27:3418-9. [PMID: 19470918 DOI: 10.1200/JCO.2009.21.9782] [Cited by in Crossref: 86] [Cited by in F6Publishing: 49] [Article Influence: 6.6] [Reference Citation Analysis]
33 Hugo HJ, Saunders C, Ramsay RG, Thompson EW. New Insights on COX-2 in Chronic Inflammation Driving Breast Cancer Growth and Metastasis. J Mammary Gland Biol Neoplasia 2015;20:109-19. [DOI: 10.1007/s10911-015-9333-4] [Cited by in Crossref: 53] [Cited by in F6Publishing: 54] [Article Influence: 7.6] [Reference Citation Analysis]
34 Hashemi SH, Karimi S, Mahboobi H. Lifestyle changes for prevention of breast cancer. Electron Physician 2014;6:894-905. [PMID: 25763165 DOI: 10.14661/2014.894-905] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
35 Bosetti C, Rosato V, Gallus S, Cuzick J, La Vecchia C. Aspirin and cancer risk: a quantitative review to 2011. Ann Oncol. 2012;23:1403-1415. [PMID: 22517822 DOI: 10.1093/annonc/mds113] [Cited by in Crossref: 210] [Cited by in F6Publishing: 195] [Article Influence: 21.0] [Reference Citation Analysis]
36 Ni X, Ma J, Zhao Y, Wang Y, Wang S. Meta-analysis on the association between non-steroidal anti-inflammatory drug use and ovarian cancer. Br J Clin Pharmacol 2013;75:26-35. [PMID: 22471948 DOI: 10.1111/j.1365-2125.2012.04290.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
37 Wu JW, Boudreau DM, Park Y, Simonds NI, Freedman AN. Commonly used diabetes and cardiovascular medications and cancer recurrence and cancer-specific mortality: a review of the literature. Expert Opin Drug Saf 2014;13:1071-99. [PMID: 24999107 DOI: 10.1517/14740338.2014.926887] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
38 Cronin-Fenton DP, Pedersen L, Lash TL, Friis S, Baron JA, Sørensen HT. Prescriptions for selective cyclooxygenase-2 inhibitors, non-selective non-steroidal anti-inflammatory drugs, and risk of breast cancer in a population-based case-control study. Breast Cancer Res 2010;12:R15. [PMID: 20193065 DOI: 10.1186/bcr2482] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
39 Heaney A, Buggy DJ. Can anaesthetic and analgesic techniques affect cancer recurrence or metastasis? Br J Anaesth 2012;109 Suppl 1:i17-28. [PMID: 23242747 DOI: 10.1093/bja/aes421] [Cited by in Crossref: 141] [Cited by in F6Publishing: 120] [Article Influence: 15.7] [Reference Citation Analysis]
40 Christodoulatos GS, Spyrou N, Kadillari J, Psallida S, Dalamaga M. The Role of Adipokines in Breast Cancer: Current Evidence and Perspectives. Curr Obes Rep 2019;8:413-33. [PMID: 31637624 DOI: 10.1007/s13679-019-00364-y] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 12.5] [Reference Citation Analysis]
41 Horn SL, Fentiman IS. The Role of Non-Steroidal Anti-Inflammatory Drugs in the Chemoprevention of Breast Cancer. Pharmaceuticals (Basel) 2010;3:1550-60. [PMID: 27713317 DOI: 10.3390/ph3051550] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
42 Cuzick J, Decensi A, Arun B, Brown PH, Castiglione M, Dunn B, Forbes JF, Glaus A, Howell A, von Minckwitz G, Vogel V, Zwierzina H. Preventive therapy for breast cancer: a consensus statement. The Lancet Oncology 2011;12:496-503. [DOI: 10.1016/s1470-2045(11)70030-4] [Cited by in Crossref: 167] [Cited by in F6Publishing: 70] [Article Influence: 15.2] [Reference Citation Analysis]
43 Vaught DB, Stanford JC, Cook RS. Efferocytosis creates a tumor microenvironment supportive of tumor survival and metastasis. Cancer Cell Microenviron 2015;2:e666. [PMID: 29264372 DOI: 10.14800/ccm.666] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
44 Luo T, Yan HM, He P, Luo Y, Yang YF, Zheng H. Aspirin use and breast cancer risk: a meta-analysis. Breast Cancer Res Treat. 2012;131:581-587. [PMID: 21898115 DOI: 10.1007/s10549-011-1747-0] [Cited by in Crossref: 57] [Cited by in F6Publishing: 51] [Article Influence: 5.2] [Reference Citation Analysis]
45 Kinoshita T, Goto T. Links between Inflammation and Postoperative Cancer Recurrence. J Clin Med 2021;10:E228. [PMID: 33435255 DOI: 10.3390/jcm10020228] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
46 Bardia A, Olson JE, Vachon CM, Lazovich D, Vierkant RA, Wang AH, Limburg PJ, Anderson KE, Cerhan JR. Effect of aspirin and other NSAIDs on postmenopausal breast cancer incidence by hormone receptor status: results from a prospective cohort study. Breast Cancer Res Treat. 2011;126:149-155. [PMID: 20669045 DOI: 10.1007/s10549-010-1074-x] [Cited by in Crossref: 58] [Cited by in F6Publishing: 57] [Article Influence: 4.8] [Reference Citation Analysis]
47 Moris D, Kontos M, Spartalis E, Fentiman IS. The Role of NSAIDs in Breast Cancer Prevention and Relapse: Current Evidence and Future Perspectives. Breast Care (Basel) 2016;11:339-44. [PMID: 27920627 DOI: 10.1159/000452315] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
48 Kastrati I, Litosh VA, Zhao S, Alvarez M, Thatcher GR, Frasor J. A novel aspirin prodrug inhibits NFκB activity and breast cancer stem cell properties. BMC Cancer 2015;15:845. [PMID: 26530254 DOI: 10.1186/s12885-015-1868-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
49 Stone J, Willenberg L, Apicella C, Treloar S, Hopper J. The association between mammographic density measures and aspirin or other NSAID use. Breast Cancer Res Treat 2012;132:259-66. [PMID: 22037829 DOI: 10.1007/s10549-011-1834-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
50 Xu J, Yin Z, Gao W, Liu L, Wang R, Huang P, Yin Y, Liu P, Yu R, Shu Y. Meta-analysis on the association between nonsteroidal anti-inflammatory drug use and lung cancer risk. Clin Lung Cancer 2012;13:44-51. [PMID: 21813335 DOI: 10.1016/j.cllc.2011.06.009] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.6] [Reference Citation Analysis]
51 Suman S, Sharma PK, Rai G, Mishra S, Arora D, Gupta P, Shukla Y. Current perspectives of molecular pathways involved in chronic inflammation-mediated breast cancer. Biochem Biophys Res Commun 2016;472:401-9. [PMID: 26522220 DOI: 10.1016/j.bbrc.2015.10.133] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 4.9] [Reference Citation Analysis]
52 Han WH, Oh YJ, Eom BW, Yoon HM, Kim YW, Ryu KW. Prognostic impact of infectious complications after curative gastric cancer surgery. Eur J Surg Oncol 2020;46:1233-8. [PMID: 32362466 DOI: 10.1016/j.ejso.2020.04.032] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
53 Finetti F, Travelli C, Ercoli J, Colombo G, Buoso E, Trabalzini L. Prostaglandin E2 and Cancer: Insight into Tumor Progression and Immunity. Biology (Basel) 2020;9:E434. [PMID: 33271839 DOI: 10.3390/biology9120434] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 9.0] [Reference Citation Analysis]
54 Low YS, Daugherty AC, Schroeder EA, Chen W, Seto T, Weber S, Lim M, Hastie T, Mathur M, Desai M, Farrington C, Radin AA, Sirota M, Kenkare P, Thompson CA, Yu PP, Gomez SL, Sledge GW Jr, Kurian AW, Shah NH. Synergistic drug combinations from electronic health records and gene expression. J Am Med Inform Assoc 2017;24:565-76. [PMID: 27940607 DOI: 10.1093/jamia/ocw161] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
55 Lee HH, Tsan YT, Ho WC, Lin MH, Lee CH, Tseng CD, Guo YL, Wang JD, Chen PC; Health Data Analysis in Taiwan (hDATa) Research Group. Angiotensin-converting enzyme inhibitors enhance the effect of cyclooxygenase inhibitors on breast cancer: a nationwide case-control study. J Hypertens 2012;30:2432-9. [PMID: 23027181 DOI: 10.1097/HJH.0b013e328358d42f] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
56 Marzbany M, Bishayee A, Rasekhian M. Increased expression of ZNF 703 in breast cancer tissue: An opportunity for RNAi-NSAID combinatorial therapy. Biotechnol Appl Biochem 2019;66:808-14. [PMID: 31195426 DOI: 10.1002/bab.1790] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
57 Liu Y, Lu Y, Wang J, Xie L, Li T, He Y, Peng Q, Qin X, Li S. Association between nonsteroidal anti-inflammatory drug use and brain tumour risk: a meta-analysis. Br J Clin Pharmacol 2014;78:58-68. [PMID: 24341448 DOI: 10.1111/bcp.12311] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
58 Du ZQ, Zhao JZ, Dong J, Bi JB, Ren YF, Zhang J, Khalid B, Wu Z, Lv Y, Zhang XF, Wu RQ. Effect of low-dose aspirin administration on long-term survival of cirrhotic patients after splenectomy: A retrospective single-center study. World J Gastroenterol 2019; 25(28): 3798-3807 [PMID: 31391774 DOI: 10.3748/wjg.v25.i28.3798] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
59 Farrugia G, Balzan R. The proapoptotic effect of traditional and novel nonsteroidal anti-inflammatory drugs in mammalian and yeast cells. Oxid Med Cell Longev 2013;2013:504230. [PMID: 23983899 DOI: 10.1155/2013/504230] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]